Compare ITIC & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ITIC | SMTI |
|---|---|---|
| Founded | 1972 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 444.2M | 182.6M |
| IPO Year | 1995 | 2008 |
| Metric | ITIC | SMTI |
|---|---|---|
| Price | $240.81 | $22.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $34.00 |
| AVG Volume (30 Days) | 19.4K | ★ 37.9K |
| Earning Date | 05-04-2026 | 05-12-2026 |
| Dividend Yield | ★ 4.43% | N/A |
| EPS Growth | ★ 13.02 | N/A |
| EPS | ★ 3.20 | 0.05 |
| Revenue | ★ $272,755,000.00 | $15,586,976.00 |
| Revenue This Year | N/A | $17.31 |
| Revenue Next Year | N/A | $12.48 |
| P/E Ratio | ★ $76.38 | $476.50 |
| Revenue Growth | 5.60 | ★ 32.47 |
| 52 Week Low | $190.20 | $16.05 |
| 52 Week High | $288.98 | $35.70 |
| Indicator | ITIC | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 53.84 | 64.61 |
| Support Level | $229.64 | $22.60 |
| Resistance Level | $247.37 | $25.14 |
| Average True Range (ATR) | 6.56 | 1.48 |
| MACD | 0.27 | 0.37 |
| Stochastic Oscillator | 76.90 | 77.52 |
Investors Title Co operates in the title insurance and exchange services sectors. The Company has two reportable segments. The Company's primary business activity, and one of its reportable operating segments, is the issuance of residential and commercial title insurance through ITIC and NITIC. The company's second reportable operating segment is providing tax-deferred real property exchange services through its subsidiaries, Investors Title Exchange Corporation (ITEC) and Investors Title Accommodation Corporation (ITAC).
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.